Ignite Creation Date:
2025-12-24 @ 11:47 AM
Ignite Modification Date:
2025-12-30 @ 3:28 PM
Study NCT ID:
NCT07179861
Status:
COMPLETED
Last Update Posted:
2025-09-23
First Post:
2025-09-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparing Artificial Intelligence and Physicians: A Vignette-Based Study in Pediatric Clinical Decision-Making
Sponsor:
Haseki Training and Research Hospital
Organization:
Study Overview
Official Title:
A Prospective, Cross-Sectional, Vignette-Based Observational Study Comparing Clinical Decision-Making Performance of Pediatriciansand AI Models
Status:
COMPLETED
Status Verified Date:
2025-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates how well anonymized artificial-intelligence (AI) tools perform on standardized pediatric case vignettes and whether showing AI suggestions can improve clinicians' answers. About 30 board-certified/eligible pediatric specialists at a single hospital complete a one-time session. Participants are randomized to two groups. Group A (n≈15): physicians answer each vignette once. Group B (n≈15): physicians answer and rate confidence (1-10), then review anonymized suggestions from five different AI tools (tool names not shown) and may keep or change their answer; changes and confidence are recorded.
Primary focus: measure AI performance (diagnostic accuracy, medication-dosing accuracy, interpretation accuracy) overall and by difficulty tier, and record AI response time. Secondary focus: quantify how AI suggestions affect human performance (change in accuracy, direction of change, confidence shift, and time). No patients or biospecimens are involved; risks are minimal (time and possible discomfort with performance review). Findings may inform safe, evidence-based ways to use AI alongside clinicians in pediatrics.
Primary focus: measure AI performance (diagnostic accuracy, medication-dosing accuracy, interpretation accuracy) overall and by difficulty tier, and record AI response time. Secondary focus: quantify how AI suggestions affect human performance (change in accuracy, direction of change, confidence shift, and time). No patients or biospecimens are involved; risks are minimal (time and possible discomfort with performance review). Findings may inform safe, evidence-based ways to use AI alongside clinicians in pediatrics.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: